Head of Process Analytical Technology - Mammalian Platform jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sanofi · 6 hours ago

Head of Process Analytical Technology - Mammalian Platform

Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives. The Head of Process Analytical Technology will lead the development and implementation of Process Analytical Technology for the Mammalian Platform, focusing on innovation and technology implementation in clinical and commercial manufacturing.

Health CareLife SciencePharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

Lead the development and implementation of Process Analytical Technology for the Mammalian Platform, including cell culture and purification applications
Drive the design and evolution of our Process Analytical Technology roadmap to enable near-term implementation and long-term disruptive innovation
Represent the Mammalian Platform for PAT-related topics, interfacing with Commercial Manufacturing and Quality, as well as other Platforms within R&D (Microbial, Genomic Medicines, mRNA, Vaccines, Synthetics)
Engage relevant stakeholders across R&D and Commercial Manufacturing to ensure resources, budget, and implementation risk are adequately managed and communicated
Identify opportunities to improve our process development strategies and manufacturing approaches through the application of PAT
Act as a PAT champion across the Sanofi R&D and Manufacturing network
Mentor scientists across sites and teams fostering their career development and professional growth

Qualification

Process Analytical TechnologySpectroscopic techniquesOnline/inline analyzersDigital architectureRegulatory frameworksUpstream/downstream operationsProduct quality attributesScientific curiosityLeadership skillsCommunication skills

Required

PhD. in Biochemical Engineering, Chemical Engineering, Analytical Chemistry, Physics, Bioengineering, Electrical Engineering, or related fields with at least 7 years of experience or a M.S. with at least 11 years of relevant experience or a B.S. with at least 12 years of relevant experience
Relevant industrial experience and/or academic experience in Process Analytical Technology development

Preferred

Experience with spectroscopic Process Analytical Technology (Raman, Near-Infrared, Mid-Infrared, Fluorescence, UV-Vis) techniques
Experience with online or inline analyzers for Process Analytical Technology applications (HPLC, UPLC, LCMS, DLS, MALS) and auto-sampling techniques
Understanding of PAT-enabling digital architecture and its application in manufacturing settings (SynTQ, SIMCA-Online, Distributed Control Systems)
Familiarity with relevant Regulatory and Quality frameworks related to control strategy, method qualification, process validation, and data integrity
Understanding of upstream and downstream unit operations, process development, and technology transfer
Understanding of product quality attributes of therapeutic proteins (antibodies, multi-specific antibodies, fusion proteins, enzymes)
Ability to lead a diverse, cross-functional, cross-site matrixed team
Excellent communication skills in both written and oral settings
High level of scientific curiosity and innovation mindset

Benefits

High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave

Company

Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.

H1B Sponsorship

Sanofi has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)

Funding

Current Stage
Public Company
Total Funding
$6.97B
Key Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B

Leadership Team

leader-logo
Paul Hudson
Chief Executive Officer
linkedin
leader-logo
Francois-Xavier Roger
Chief Financial Officer
linkedin
Company data provided by crunchbase